The lymphatic vasculature system is a critical, yet underappreciated component of all immunological processes. Rho Bio is a first-in-class biologic solution aimed to bring novel therapeutic solutions targeted at lymphatic vasculature. Rho Bio aims to be the leading biotech company focused on lymphatic biology. We engineered lymphatic-specific VEGF-C muteins (LS-VEGF-C) using directed evolution.